• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生血管性年龄相关性黄斑变性的疾病负担与医疗资源利用:一项多国研究的结果

Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study.

作者信息

Soubrane Gisèle, Cruess Alan, Lotery Andrew, Pauleikhoff Daniel, Monès Jordi, Xu Xiao, Zlateva Gergana, Buggage Ronald, Conlon John, Goss Thomas F

机构信息

Department of Ophthalmology, University Paris XII, Centre Hospitalier Intercommunal de Créteil, 40 Avenue de Verdun, Créteil, France.

出版信息

Arch Ophthalmol. 2007 Sep;125(9):1249-54. doi: 10.1001/archopht.125.9.1249.

DOI:10.1001/archopht.125.9.1249
PMID:17846366
Abstract

OBJECTIVE

To describe the burden of bilateral neovascular age-related macular degeneration (NV-AMD) on patient-reported functioning and health resource utilization.

METHODS

A cross-sectional study of 401 patients with bilateral NV-AMD and 471 elderly control subjects without AMD was conducted in 5 countries. Subjects completed a telephone survey, including the National Eye Institute 25-Item Visual Function Questionnaire, the EuroQol instrument, the Hospital Anxiety and Depression Scale, and history of falls, fractures, and health care resource utilization.

RESULTS

The mean age for patients with NV-AMD was 78.1 years, and 65% were women. The patients reported 45% worse vision-related functioning, 13% worse overall well-being, and 30% more anxiety and 42% more depression symptoms than controls after adjusting for covariates (all, P < .001). The effect of NV-AMD was also observed as a doubled fall rate (16% vs 8% [P < .001]) and a quadrupled need for assistance with daily activities (29% vs 7% [P < .001]) in the patients compared with controls.

CONCLUSIONS

The evidence of extensive decline in quality of life and increased need of daily living assistance for patients with NV-AMD compared with a control population substantiates the need for new treatments that prevent vision loss and progression to blindness.

摘要

目的

描述双侧新生血管性年龄相关性黄斑变性(NV-AMD)对患者报告的功能和健康资源利用的负担。

方法

在5个国家对401例双侧NV-AMD患者和471例无AMD的老年对照者进行了一项横断面研究。受试者完成了一项电话调查,包括美国国立眼科研究所25项视觉功能问卷、欧洲五维度健康量表、医院焦虑抑郁量表,以及跌倒、骨折和医疗资源利用史。

结果

NV-AMD患者的平均年龄为78.1岁,65%为女性。在调整协变量后,患者报告的与视力相关的功能比对照组差45%,总体幸福感差13%,焦虑症状多30%,抑郁症状多42%(均P<0.001)。与对照组相比,还观察到NV-AMD患者的跌倒率增加了一倍(16%对8%[P<0.001]),日常生活需要协助的需求增加了两倍(29%对7%[P<0.001])。

结论

与对照人群相比,NV-AMD患者生活质量大幅下降且日常生活协助需求增加的证据,证实了需要有预防视力丧失和失明进展的新治疗方法。

相似文献

1
Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study.新生血管性年龄相关性黄斑变性的疾病负担与医疗资源利用:一项多国研究的结果
Arch Ophthalmol. 2007 Sep;125(9):1249-54. doi: 10.1001/archopht.125.9.1249.
2
Burden of illness of neovascular age-related macular degeneration in Canada.加拿大新生血管性年龄相关性黄斑变性的疾病负担。
Can J Ophthalmol. 2007 Dec;42(6):836-43. doi: 10.3129/i07-153.
3
Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.双侧新生血管性年龄相关性黄斑变性的经济负担:多国观察性研究。
Pharmacoeconomics. 2008;26(1):57-73. doi: 10.2165/00019053-200826010-00006.
4
Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study.新生血管性年龄相关性黄斑变性患者的疾病负担、视力损害及健康资源利用情况:一项五国横断面研究英国队列的结果
Br J Ophthalmol. 2007 Oct;91(10):1303-7. doi: 10.1136/bjo.2007.116939. Epub 2007 May 15.
5
[Neovascular age-related macular degeneration in Germany. Encroachment on the quality of life and the financial implications].[德国的新生血管性年龄相关性黄斑变性。对生活质量的影响及经济负担]
Ophthalmologe. 2009 Mar;106(3):242-51. doi: 10.1007/s00347-008-1797-9.
6
[Humanistic burden and health resource utilization among neovascular age-related macular degeneration patients in France].[法国新生血管性年龄相关性黄斑变性患者的人文负担与卫生资源利用情况]
J Fr Ophtalmol. 2008 Feb;31(2):138-45. doi: 10.1016/s0181-5512(08)70346-2.
7
Burden of illness of bilateral neovascular age-related macular degeneration in Spain.西班牙双侧新生血管性年龄相关性黄斑变性的疾病负担
Curr Med Res Opin. 2008 Jul;24(7):2103-11. doi: 10.1185/03007990802214300. Epub 2008 Jun 10.
8
Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.从视力推断新生血管性年龄相关性黄斑变性治疗对公共卫生的影响。
Invest Ophthalmol Vis Sci. 2007 Jan;48(1):96-103. doi: 10.1167/iovs.06-0283.
9
Investigating the burden of wet macular degeneration.研究湿性黄斑变性的负担。
Arch Ophthalmol. 2007 Sep;125(9):1266-8. doi: 10.1001/archopht.125.9.1266.
10
Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4.年龄相关性黄斑变性继发脉络膜新生血管患者在黄斑下手术随机试验入组时的健康及视力相关生活质量:SST报告第4号
Am J Ophthalmol. 2004 Jul;138(1):91-108. doi: 10.1016/j.ajo.2004.02.011.

引用本文的文献

1
The Economic Burden of Anti-Vascular Endothelial Growth Factor on Patients and Caregivers in the UK, Europe, and North America.抗血管内皮生长因子对英国、欧洲和北美的患者及护理人员造成的经济负担。
Ophthalmol Ther. 2025 Jun 28. doi: 10.1007/s40123-025-01180-5.
2
Association of Metabolomics With Incidence of Age-Related Macular Degeneration: The UK Biobank Study.代谢组学与年龄相关性黄斑变性发病率的关联:英国生物银行研究
Invest Ophthalmol Vis Sci. 2024 Dec 2;65(14):43. doi: 10.1167/iovs.65.14.43.
3
Economic Burden of Late-Stage Age-Related Macular Degeneration in Bulgaria, Germany, and the US.
保加利亚、德国和美国晚期年龄相关性黄斑变性的经济负担
JAMA Ophthalmol. 2024 Dec 1;142(12):1123-1130. doi: 10.1001/jamaophthalmol.2024.4401.
4
The association between visual impairment and mental disorders.视力障碍与精神障碍之间的关联。
Sci Rep. 2024 Jan 27;14(1):2301. doi: 10.1038/s41598-024-52389-6.
5
The risk of fracture in age-related macular degeneration according to the presence of visual disability: a nationwide cohort study.根据视力残疾情况分析年龄相关性黄斑变性患者的骨折风险:一项全国性队列研究
Eye (Lond). 2024 Feb;38(2):364-371. doi: 10.1038/s41433-023-02699-2. Epub 2023 Aug 19.
6
The effects of age-related macular degeneration on work productivity: A meta-analysis.年龄相关性黄斑变性对工作效率的影响:一项荟萃分析。
Eur J Ophthalmol. 2024 May;34(3):641-648. doi: 10.1177/11206721231185808. Epub 2023 Jul 14.
7
Complement inhibitors for age-related macular degeneration.用于年龄相关性黄斑变性的补体抑制剂。
Cochrane Database Syst Rev. 2023 Jun 14;6(6):CD009300. doi: 10.1002/14651858.CD009300.pub3.
8
The effects of age and central field loss on maintaining balance control when stepping up to a new level under time-pressure.年龄和中央视野缺失对在时间压力下迈向新高度时维持平衡控制的影响。
PeerJ. 2023 Feb 20;11:e14743. doi: 10.7717/peerj.14743. eCollection 2023.
9
Patient Preferences in the Management of Wet Age-Related Macular Degeneration: A Conjoint Analysis.患者对湿性年龄相关性黄斑变性治疗选择的偏好:联合分析。
Adv Ther. 2022 Oct;39(10):4808-4820. doi: 10.1007/s12325-022-02248-5. Epub 2022 Aug 22.
10
Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies.Brolucizumab 治疗退行性黄斑病变:临床研究综述。
Drug Des Devel Ther. 2022 Aug 9;16:2659-2680. doi: 10.2147/DDDT.S378450. eCollection 2022.